Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Vascular Neurology
•
Endocrinology
•
Transgender Care
•
Male and Female Reproductive Disorders
What estradiol patch dose do you recommend for transgender adult patients with prior history of stroke or myocardial infarction?
Related Questions
In ischemic stroke patients with low LDL levels (<30-50 mg/dl), would you consider lowering LDL levels to lower values without concern for any side effects?
What is the optimal BP target for patients with diabetes and hypertension to reduce their risk of MI/stroke?
Is moderate-intensity statin plus ezetimibe just as effective as high-intensity statin monotherapy in preventing major cardiovascular events?
How would you approach antithrombotic therapy in patients with acute ischemic infarcts and a non-occlusive intracranial thrombus?
Do you recommend a trial of testosterone replacement therapy in male patients with symptoms consistent with hypogonadism, low total testosterone but normal free androgen index (FAI)?
Do oral contraceptives lower bone mineral density in women with hypothalamic amenorrhea by lowering IGF-1?
Would you recommend anticoagulation in a pediatric patient with metastases in a dural venous sinus?
Do you recommend starting testosterone replacement therapy in male patients with hypogonadism symptoms, total testosterone levels at the higher end of normal (above 500) but low free testosterone?
When do you consider testing with stroke gene panels in young stroke patients?
How do you counsel patients who develop DVT or atrial fibrillation requiring anticoagulation when being treated with lecanemab or donanemab?